Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 153" is a **processed pseudogene** related to the 5S ribosomal RNA gene family and is classified as a non-coding RNA pseudogene. Pseudogenes like RNA5SP153 are DNA sequences that resemble functional genes (in this case, 5S rRNA) but have lost coding ability due to mutations such as insertions, deletions, or premature stop codons. Most pseudogenes are not transcribed or translated and do not produce functional products, thus have no known canonical biological function, direct pharmacological relevance, or therapeutic targeting utility. While a subset of pseudogenes in the genome may influence gene regulation or serve as disease biomarkers, there is no evidence that RNA5SP153 plays such a role. Pseudogenes are maintained in the genome as remnants of gene duplication or retrotransposition events and are generally categorized as "junk DNA," although recent research recognizes some may occasionally acquire regulatory functions[2][8][14][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 153 (RNA5SP153).